Abstract
Metabolic profiling, metabolomic and metabonomic studies mainly involve the multicomponent analysis of biological fluids, tissue and cell extracts using NMR spectroscopy and/or mass spectrometry (MS). We summarize the main NMR spectroscopic applications in modern metabolic research, and provide detailed protocols for biofluid (urine, serum/plasma) and tissue sample collection and preparation, including the extraction of polar and lipophilic metabolites from tissues. 1H NMR spectroscopic techniques such as standard 1D spectroscopy, relaxation-edited, diffusion-edited and 2D J-resolved pulse sequences are widely used at the analysis stage to monitor different groups of metabolites and are described here. They are often followed by more detailed statistical analysis or additional 2D NMR analysis for biomarker discovery. The standard acquisition time per sample is 4–5 min for a simple 1D spectrum, and both preparation and analysis can be automated to allow application to high-throughput screening for clinical diagnostic and toxicological studies, as well as molecular phenotyping and functional genomics.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fiehn, O. Metabolomics—the link between genotypes and phenotypes. Plant Mol. Biol. 48, 155–171 (2002).
Nicholson, J.K., Lindon, J.C. & Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181–1189 (1999).
Bell, J.D., Sadler, P.J., Morris, V.C. & Levander, O.A. Effect of ageing and diet on proton NMR spectra of rat urine. Magn. Reson. Med. 17, 414–422 (1991).
Bollard, M.E. et al. Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high resolution 1H NMR spectroscopy of urine and pattern recognition. Anal. Biochem. 295, 194–202 (2001).
Phipps, A.N., Wright, B., Stewart, J. & Wilson, I.D. Use of proton NMR for determining changes in metabolite excretion profiles induced by dietary changes in the rat. Pharm. Sci. 3, 143–146 (1997).
Gavaghan, C.L., Wilson, I.D. & Nicholson, J.K. Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLSDA. FEBS Lett. 530, 191–196 (2002).
Holmes, E. et al. Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem. Res. Toxicol. 13, 471–478 (2000).
Gartland, K.P., Bonner, F.W. & Nicholson, J.K. Investigations into the biochemical effects of region-specific nephrotoxic lesions. Mol. Pharmacol. 35, 242–250 (1989).
Beckwith-Hall, B.M. et al. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem. Res. Toxicol. 11, 260–272 (1998).
Robertson, D.G., Reily, M.D., Lindon, J.C., Holmes, E. & Nicholson, J.K. Metabonomic technology as a tool for rapid throughput in vivo toxicity screening. in Compr. Toxicol., Molecular and Cell. Toxicol., 14, 583–610, eds. Vanden Heuvel, J.P., Perdew, G.H., Mattes, W.B., Greenlee, W.F., Elsevier (2002).
Garrod, S. et al. High resolution magic angle spinning 1H NMR spectroscopic studies on intact rat renal cortex and medulla. Magn. Reson. Med. 41, 1108–1118 (1999).
Moka, D. et al. Biochemical classification of kidney carcinoma biopsy samples using magic-angle-spinning 1H nuclear magnetic resonance spectroscopy. J. Pharm. Biomed. Anal. 17, 125–132 (1998).
Cheng, L.L. & Pohl, U. The role of NMR-based metabolomics in cancer. in Handbook of Metabonomics and Metabolomics (eds. Lindon, J.C., Nicholson, J.K. & Holmes, E.) 345–374 (Elsevier, Amsterdam, 2006).
Swanson, M.G. et al. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn. Reson. Med. 50, 944–954 (2003).
Bollard, M.E. et al. Metabolic profiling of the effects of D-galactosamine in liver spheroids using 1H NMR and MAS NMR spectroscopy. Chem. Res. Toxicol. 15, 1351–1359 (2002).
Nicholson, J.K., Foxall, P.J., Spraul, M., Farrant, R.D. & Lindon, J.C. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal. Chem. 67, 793–811 (1995).
Teahan, O. et al. Impact of analytical bias in metabonomic studies of human blood serum and plasma. Anal. Chem. 78, 4307–4318 (2006).
Waters, N.J., Holmes, E., Waterfield, C.J., Farrant, R.D. & Nicholson, J.K. NMR and pattern recognition studies on liver extracts and intact livers from rats treated with α-napthylisothiocyanate. Biochem. Pharmacol. 64, 67–77 (2002).
Coen, M. et al. An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem. Res. Toxicol. 16, 295–303 (2003).
Wang, Y. et al. Spectral editing and pattern recognition methods applied to high-resolution magic-angle spinning 1H nuclear magnetic resonance spectroscopy of liver tissues. Anal. Biochem. 323, 26–32 (2003).
Keun, H.C. et al. Analytical reproducibility in 1H NMR-based metabonomic urinalysis. Chem. Res. Toxicol. 15, 1380–1386 (2002).
Brown, F.F., Campbell, I.D., Kuchel, P.W. & Rabenstein, D.C. Human erythrocyte metabolism studies by 1H spin echo NMR. FEBS Lett. 82, 12–16 (1977).
Brindle, K.M., Brown, F.F., Campbell, I.D., Grathwohl, C. & Kuchel, P.W. Application of spin-echo nuclear magnetic resonance to whole-cell systems. Membrane transport. Biochem. J. 180, 37–44 (1979).
Nicholson, J.K., Buckingham, M.J. & Sadler, P.J. High resolution 1H n.m.r. studies of vertebrate blood and plasma. Biochem. J. 211, 605–615 (1983).
Nicholson, J.K. et al. Proton nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. Biochem. J. 217, 365–375 (1984).
Nicholson, J.K., Timbrell, J.A. & Sadler, P.J. Proton NMR spectra of urine as indicators of renal damage. Mercury-induced nephrotoxicity in rats. Mol. Pharmacol. 27, 644–651 (1985).
Nicholson, J.K. & Wilson, I.D. High resolution proton magnetic resonance spectroscopy of biological fluids. Prog. Nucl. Magn. Reson. Spectrosc. 21, 449–501 (1989).
Nicholson, J.K., Connelly, J., Lindon, J.C. & Holmes, E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1, 153–162 (2002).
Lindon, J.C., Nicholson, J.K. & Holmes, E. (eds.) The Handbook of Metabonomics and Metabolomics (Elsevier, Amsterdam, 2006).
Bollard, M.E., Stanley, E.G., Lindon, J.C., Nicholson, J.K. & Holmes, E. NMR-based metabonomics approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 18, 143–162 (2005).
Bales, J.R., Sadler, P.J., Nicholson, J.K. & Timbrell, J.A. Urinary excretion of acetaminophen and its metabolites as studied by proton NMR spectroscopy. Clin. Chem. 30, 1631–1636 (1984).
Lenz, E.M. & Wilson, I.D. Analytical strategies in metabonomics. J. Proteome Res. 6, 443–458 (2007).
van der Greef, J. et al. Evaluation of field desorption and fast atom-bombardment mass spectrometric profiles by pattern recognition techniques. Anal. Chim. Acta 150, 45–52 (1983).
Wilson, I.D. et al. High resolution “ultra performance” liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J. Proteome Res. 4, 591–598 (2005).
Gartland, K.P. et al. Pattern recognition analysis of high resolution 1H NMR spectra of urine. A nonlinear mapping approach to the classification of toxicological data. NMR Biomed. 3, 166–172 (1990).
Gartland, K.P., Beddell, C.R., Lindon, J.C. & Nicholson, J.K. The application of pattern recognition methods to the analysis and classification of toxicological data derived from proton NMR spectroscopy of urine. Mol. Pharmacol. 39, 629–642 (1991).
Ebbels, T. et al. Toxicity classification from metabonomic data using a density superposition approach: 'CLOUDS'. Anal. Chim. Acta 490, 109–122 (2003).
Antti, H. et al. Statistical experimental design and partial least squares regression analysis of biofluid metabonomic NMR and clinical chemistry data for screening of adverse drug effects. Chemom. Intell. Lab. Syst. 73, 139–149 (2004).
Cloarec, O. et al. Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Anal. Chem. 77, 1282–1289 (2005).
Crockford, D.J. et al. Statistical HeterospectroscopY (SHY), a new approach to the integrated analysis of NMR and UPLC-MS datasets: application in metabonomic toxicology studies. Anal. Chem. 78, 363–371 (2006).
Lindon, J.C. et al. Contemporary issues in toxicology—the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol. 187, 137–146 (2003).
Lindon, J.C. et al. The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. Pharmacogenomics 6, 691–699 (2005).
Ebbels, T.M.D. et al. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: The Consortium of Metabonomic Toxicology Screening approach. J. Proteome Res. 6, 3944–3951 (2007).
Lindon, J.C. & Holmes, E. A survey of metabonomics approaches for disease characterization. In Handbook of Metabonomics and Metabolomics (eds. Lindon, J.C., Nicholson, J.K. & Holmes, E.) 413–442 (Elsevier, Amsterdam, 2006).
Moolenaar, S.H., Engelke, U.F. & Wevers, R.A. Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann. Clin. Biochem. 40, 16–24 (2003).
Brindle, J.T. et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H NMR-based metabonomics. Nat. Med. 8, 1439–1445 (2002).
Nicholls, A.W., Mortishire-Smith, R.J. & Nicholson, J.K. NMR spectroscopic based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem. Res. Toxicol. 16, 1395–1404 (2003).
Nicholson, J.K., Holmes, E. & Wilson, I.D. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 3, 431–438 (2005).
Clayton, T.A. et al. Pharmaco-metabonomic phenotyping and personalised drug treatment. Nature 440, 1073–1077 (2006).
Dumas, M.E. et al. Assessment of analytical reproducibilty of 1H nmr spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP study. Anal. Chem. 78, 2199–2208 (2006).
Liu, M., Nicholson, J.K. & Lindon, J.C. High resolution diffusion and relaxation edited one- and two-dimensional 1H NMR spectroscopy of biological fluids. Anal. Chem. 68, 3370–3376 (1996).
Jenkins, H. et al. A proposed framework for the description of plant metabolomics experiments and their results. Nat. Biotechnol. 22, 1601–1606 (2004).
Bino, R.J. et al. Potential of metabolomics as a functional genomics tool. Trends Plant Sci. 9, 418–425 (2004).
Lindon, J.C. et al. Summary recommendations for standardization and reporting of metabolic analyses. Nat. Biotechnol. 23, 833–838 (2005).
Le Belle, J.E., Harris, N.G., Williams, S.R. & Bhakoo, K.K. A comparison of cell and tissue extraction techniques using high-resolution 1H-NMR spectroscopy. NMR Biomed. 15, 37–44 (2002).
Ching, Y.L., Wu, H., Tjeerdema, R.S. & Viant, M.R. Evaluation of metabolite extraction strategies from tissue samples using NMR metabolomics. Metabolomics 3, 55–67 (2007).
Villas-Boas, S.G., Hojer-Pedersen, J., Akesson, M., Smedsgaard, J. & Nielsen, J. Global metabolite analysis of yeast: evaluation of sample preparation methods. Yeast 22, 1155–1169 (2005).
Ippolito, J.E. et al. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc. Natl. Acad. Sci. USA 102, 9901–9906 (2005).
Spraul, M. et al. Flow injection proton nuclear magnetic resonance spectroscopy combined with pattern recognition methods: implications for rapid structural studies and high throughput biochemical screening. Anal. Comm. 34, 339–341 (1997).
Akoka, S., Barantin, L. & Trierweiler, M. Concentration measurement by proton NMR using the ERETIC method. Anal. Chem. 71, 2554–2557 (1999).
Aue, W.P., Karhan, J. & Ernst, R.R. Homonuclear broad band decoupling and two-dimensional J-resolved NMR spectroscopy. J. Chem. Phys. 64, 4226–4227 (1976).
Aue, W.P., Bartholdi, E. & Ernst, R.R. Two-dimensional spectroscopy. Application to nuclear magnetic resonance. J. Chem. Phys. 64, 2229–2246 (1976).
Braunschweiler, L. & Ernst, R.R. Coherence transfer by isotropic mixing: application to proton correlation spectroscopy. J. Magn. Reson. 53, 521–528 (1983).
Keun, H.C. et al. Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. Anal. Chem. 74, 4588–4593 (2002).
Lindon, J.C., Nicholson, J.K. & Wilson, I.D. Directly-coupled HPLC-NMR and HPLC-NMR-MS in pharmaceutical research and development. J. Chromatogr. B 748, 233–258 (2000).
Cloarec, O. et al. Virtual chromatographic resolution enhancement in cryoflow LC-NMR experiments via statistical total correlation spectroscopy. Anal. Chem. 79, 3304–3311 (2007).
Smith, L.M. et al. Statistical correlation and projection methods for improved information recovery from diffusion-edited NMR spectra of biological samples. Anal. Chem. 79, 5682–5689 (2007).
Deprez, S., Sweatman, B.C., Connor, S.C., Haselden, J.N. & Waterfield, C.J. Optimisation of collection, storage and preparation of rat plasma for 1H NMR spectroscopic analysis in toxicology studies to determine inherent variation in biochemical profiles. J. Pharm. Biomed. Anal. 30, 1297–1310 (2002).
Maher, A.D., Zirah, S.F., Holmes, E. & Nicholson, J.K. Experimental and analytical variation in human urine in 1H NMR spectroscopy-based metabolic phenotyping studies. Anal. Chem. 79, 5204–5211 (2007).
Hwang, T.L. & Shaka, A.J. Water suppression that works: excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson. A 112, 275–279 (1995).
Aranibar, N., Ott, K.H., Roongta, V. & Mueller, L. Metabolomic analysis using optimised NMR and statistical methods. Anal. Biochem. 355, 62–70 (2006).
Sonnewald, U., Isern, E., Gribbestad, I.S. & Unsgard, G. UDP-N-acetylhexosamines and hypotaurine in human glioblastoma, normal brain tissue and cell cultures: 1H/NMR spectroscopy study. Anticancer Res. 14, 793–798 (1994).
Henke, J., Willker, W., Engelmann, J. & Leibfritz, D. Combined extraction techniques of tumour cells and lipid/phospholipid assignment by two dimensional NMR spectroscopy. Anticancer Res. 16, 1417–1427 (1996).
Bligh, E.G. & Dyer, W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911–917 (1959).
Tyagi, R.K., Azrad, A., Degani, H. & Salomon, Y. Simultaneous extraction of cellular lipids and water-soluble metabolites: evaluation by NMR spectroscopy. Magn. Reson. Med. 35, 194–200 (1996).
Beckonert, O., Monnerjahn, J., Bonk, U. & Leibfritz, D. Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps. NMR Biomed. 16, 1–11 (2003).
Meiboom, S. & Gill, D. Modified spin-echo method for measuring nuclear relaxation time. Rev. Sci. Instrum. 20, 688–691 (1958).
Wu, D., Chen, A. & Johnson, C.S. An improved diffusion-ordered spectroscopy experiment incorporating bipolar-gradient pulses. J. Magn. Reson. A 115, 260–264 (1995).
Ernst, R.R. & Anderson, W.A. Application of Fourier transform spectroscopy to magnetic resonance. Rev. Sci. Instr. 37, 93–102 (1966).
Jones, D.E. & Sternlicht, H. Fourier transform nuclear magnetic resonance I. Repetitive pulses. J. Magn. Reson. 6, 167–182 (1972).
Acknowledgements
We thank our academic and industrial collaborators for helpful discussions in the formulation of this paper, including those participating in the COMET project.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Note
NMR Pulse Sequences (PDF 386 kb)
Rights and permissions
About this article
Cite this article
Beckonert, O., Keun, H., Ebbels, T. et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2, 2692–2703 (2007). https://doi.org/10.1038/nprot.2007.376
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2007.376
This article is cited by
-
Metabolomic analysis of the serum and urine of rats exposed to diazinon, dimethoate, and cypermethrin alone or in combination
BMC Pharmacology and Toxicology (2024)
-
Circadian rhythm in turbot (Scophthalmus maximus): daily variation of blood metabolites in recirculating aquaculture systems
Metabolomics (2024)
-
Cancer metabolites: promising biomarkers for cancer liquid biopsy
Biomarker Research (2023)
-
Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle
Skeletal Muscle (2023)
-
Bull spermatozoa selected by thermotaxis exhibit high DNA integrity, specific head morphometry, and improve ICSI outcome
Journal of Animal Science and Biotechnology (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.